Download Free Therapy Over 50 Book in PDF and EPUB Free Download. You can read online Therapy Over 50 and write the review.

Traditional training in counseling and psychotherapy makes minimal distinctions on the ages of the client and therapist in the treatment process. Therapy Over 50: Aging Issues in Psychotherapy and the Therapist's Life highlights how therapy is frequently a very different process for the older client and therapist. Specifically, this book explores: a) how therapists over 50 (or approaching that life transition) experience, struggle, and enjoy doing therapy in ways that are different from when they were younger (this includes their special challenges, adaptations, fears, and joys); and b) the landscape related to working clinically with aging clients, and those approaches and strategies that work best with this population. The text also includes both current research and classic literature on the subject of aging issues in therapy, as well as current excerpts from interviews the authors will conduct with some of the most notable aging figures in the fields of counseling, social work, marriage and family therapy, and clinical psychology. Therapy Over 50 ultimately deals with the inevitable and unrelenting changes that take place along with corresponding lost and reconfigured dreams as well as the approaches and strategies that are most effective for working with this population. With an optimistic tone, Kottler and Carlson promote a philosophy of positive aging and development for the therapist and client, thereby offering hope and inspiration for both parties
In 1950 men and women in the United States had a combined life expectancy of 68.9 years, the 12th highest life expectancy at birth in the world. Today, life expectancy is up to 79.2 years, yet the country is now 28th on the list, behind the United Kingdom, Korea, Canada, and France, among others. The United States does have higher rates of infant mortality and violent deaths than in other developed countries, but these factors do not fully account for the country's relatively poor ranking in life expectancy. International Differences in Mortality at Older Ages: Dimensions and Sources examines patterns in international differences in life expectancy above age 50 and assesses the evidence and arguments that have been advanced to explain the poor position of the United States relative to other countries. The papers in this deeply researched volume identify gaps in measurement, data, theory, and research design and pinpoint areas for future high-priority research in this area. In addition to examining the differences in mortality around the world, the papers in International Differences in Mortality at Older Ages look at health factors and life-style choices commonly believed to contribute to the observed international differences in life expectancy. They also identify strategic opportunities for health-related interventions. This book offers a wide variety of disciplinary and scholarly perspectives to the study of mortality, and it offers in-depth analyses that can serve health professionals, policy makers, statisticians, and researchers.
For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal conditions. Over 50% new material representing the vast amount of information available since the Women's Health Initiative (WHI) clinical trials were completed making this the most up-to-date reference on postmenopausal women Includes several new sections on comparisons between clinical trials and observational data, urology, and pelvic support Each section is preceded by a preface to put the area into context with many chapters having suggested treatment regimens
This Third Edition of the bestselling Psychotherapy with Older Adults continues to offer students and professionals a thorough overview of psychotherapy with older adults. Using the contextual, cohort-based, maturity, specific challenge (CCMSC) model, it draws upon findings from scientific gerontology and life-span developmental psychology to describe how psychotherapy needs to be adapted for work with older adults, as well as when it is similar to therapeutic work with younger adults. Sensitively linking both research and experience, author Bob G. Knight provides a practical account of the knowledge, technique, and skills necessary to work with older adults in a therapeutic relationship. This volume considers the essentials of gerontology as well as the nature of therapy in depth, focusing on special content areas and common themes. Psychotherapy with Older Adults includes a comprehensive discussion of assessment and options for intervention. Numerous case examples illustrate the dynamics of the therapeutic task and issues covered in therapy and stress the human element in working with older adults. A concluding chapter considers ethical questions and the future of psychotherapy with older adults. The author has updated the Third Edition to reflect new research findings and has written two entirely new chapters covering psychotherapy with persons with dementia and psychotherapy with caregivers of frail older adults. Since its initial publication in 1986, the book has been used as a course text and a professional reference around the world, including translations into French, Dutch, Chinese, and Japanese. It is a vital resource for practicing therapists and counselors who work with older adults and is also ideally suited as a text for advanced students in psychology, social work, gerontology, and nursing. Praise for Previous Editions: "Bob G. Knight′s largest contribution is his excellent discussion of therapy. The book is clearly written, with a good use of summaries and case examples to clarify the major points. By linking research findings to practice experience, Knight has provided a pragmatic introduction which should be helpful to psychiatrists, psychologists, social workers, and psychiatric nurses working with older adults." —JOURNAL OF APPLIED GERONTOLOGY "I recommend this book to anyone interested in working with the elderly, partly because of the content and partly because the author presents the case for doing psychotherapy with the elderly with realism and enthusiasm." —BEHAVIOR RESEARCH & THERAPY
Evaluates evidence for an increased risk of cancer in women using combined oral contraceptives, progestogen-only hormonal contraceptives, post-menopausal estrogen therapy, and post-menopausal estrogen-progestogen therapy. Although the carcinogenicity of these preparations has been extensively investigated, the book stresses the many complex methodological issues that must be considered when interpreting findings and weighing results. Evidence of an association between use of these preparations and positive effects on health, including a reduced risk of some cancers, is also critically assessed. The first and most extensive monograph evaluates evidence of an association between the use of combined oral contraceptives and cancer at nine sites. Concerning breast cancer, the evaluation concludes that, even if the association is causal, the excess risk for breast cancer associated with patterns of use that are typical today is very small. Studies of predominantly high-dose preparations found an increased risk of hepatocellular carcinoma in the absence of hepatitis viruses. Citing these findings, the evaluation concludes that there is sufficient evidence in humans for the carcinogenicity of combined oral contraceptives. The evaluation also found sufficient evidence for the carcinogenicity of some, but not all, combined preparations in animals. Combined oral contraceptives were classified as carcinogenic to humans. The evaluation also cites conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium. Progestogen-only contraceptives are evaluated in the second monograph, which considers the association with cancer at six sites. The evaluation found no evidence of an increased risk for breast cancer. Although the evaluation found sufficient evidence in animals for the carcinogenicity of medroxyprogesterone acetate, evidence for the carcinogenicity of progestogen-only contraceptives in humans was judged inadequate. Progestogen-only contraceptives were classified as possibly carcinogenic to humans. The third monograph, on post-menopausal estrogen therapy, considers evidence of an association with cancer at eight sites. Findings from a large number of epidemiological studies indicate a small increase in the risk of breast cancer in women who have used these preparations for five years or more. Studies consistently show an association between use of post-menopausal estrogen therapy and an increased risk for endometrial cancer. Data on the association with other cancers were either inconclusive or suggested no effect on risk. The evaluation concludes that post-menopausal estrogen therapy is carcinogenic to humans. The final monograph evaluates the association between the use of post-menopausal estrogen-progestogen therapy and cancer at four sites. The evaluation of limited data on breast cancer found an increased relative risk observed with long-term use. Data were judged insufficient to assess the effects of past use and of different progestogen compounds, doses, and treatment schedules. For endometrial cancer, the evaluation found an increase in risk relative to non-users when the progestogen was added to the cycle for 10 days or fewer. Post-menopausal estrogen-progestogen therapy was classified as possibly carcinogenic to humans. Concerning post-menopausal therapy in general, the book notes that evidence of carcinogenic risks must be placed in perspective of potential benefits. The prevention of osteoporotic fractures is cited as the best-established benefit. Evidence also suggests that estrogen prevents heart disease and may prevent memory loss and dementia.
Love can be hard; and meeting someone, falling in love, and growing old together isn’t easy. But it can be especially difficult when you’re over fifty! You may have never been able to find the right one or feel like it’s too late or found the one who swept you off your feet but lost them due to an unfortunate life event, such as an accident or sickness—or you may have just grown apart. For whatever reason, if the looking, finding, and keeping have become harder with each passing year, how do you find the love you desire? How to Find and Keep a Partner after Fifty—Step by Step provides a practical and encouraging guide for you if you are over fifty and have trouble looking for love. Author Freddie C. Holmes challenges you to look within at what has happened to you in the relationship department, inviting you to change your mind-set and take action. You can then learn how to attract and embrace everything you desire in a meaningful relationship, putting you on the path to a fun-filled romance with a partner you can share your bucket list with. Dating after fifty is an adventure! The good news is that it is interesting and you have many opportunities. The reason for this is that there are more potential partners available in your age group than you would have thought. But before you can embark on meeting someone new, as with any worthwhile enterprise, there are preparations and due diligence to be done to succeed. So let’s not waste any more time! Are you ready to meet a new partner?
"This ultimate, comprehensive, and intimate guide will help you find and keep love after 50"--
An in-depth look at a much misunderstood practice, offering a fresh viewpoint on how this science can be a universally effective route to our better selves.
The original edition was the first book to provide a comprehensive overview of the ways in which animals can assist therapists with treatment of specific populations, and/or in specific settings. The second edition continues in this vein, with 7 new chapters plus substantial revisions of continuing chapters as the research in this field has grown. New coverage includes: Animals as social supports, Use of AAT with Special Needs students, the role of animals in the family- insights for clinicians, and measuring the animal-person bond. - Contributions from veterinarians, animal trainers, psychologists, and social workers - Includes guidelines and best practices for using animals as therapeutic companions - Addresses specific types of patients and environmental situations
Social isolation and loneliness are serious yet underappreciated public health risks that affect a significant portion of the older adult population. Approximately one-quarter of community-dwelling Americans aged 65 and older are considered to be socially isolated, and a significant proportion of adults in the United States report feeling lonely. People who are 50 years of age or older are more likely to experience many of the risk factors that can cause or exacerbate social isolation or loneliness, such as living alone, the loss of family or friends, chronic illness, and sensory impairments. Over a life course, social isolation and loneliness may be episodic or chronic, depending upon an individual's circumstances and perceptions. A substantial body of evidence demonstrates that social isolation presents a major risk for premature mortality, comparable to other risk factors such as high blood pressure, smoking, or obesity. As older adults are particularly high-volume and high-frequency users of the health care system, there is an opportunity for health care professionals to identify, prevent, and mitigate the adverse health impacts of social isolation and loneliness in older adults. Social Isolation and Loneliness in Older Adults summarizes the evidence base and explores how social isolation and loneliness affect health and quality of life in adults aged 50 and older, particularly among low income, underserved, and vulnerable populations. This report makes recommendations specifically for clinical settings of health care to identify those who suffer the resultant negative health impacts of social isolation and loneliness and target interventions to improve their social conditions. Social Isolation and Loneliness in Older Adults considers clinical tools and methodologies, better education and training for the health care workforce, and dissemination and implementation that will be important for translating research into practice, especially as the evidence base for effective interventions continues to flourish.